Viewing Study NCT06641557


Ignite Creation Date: 2025-12-24 @ 7:02 PM
Ignite Modification Date: 2026-03-22 @ 1:06 AM
Study NCT ID: NCT06641557
Status: COMPLETED
Last Update Posted: 2025-03-11
First Post: 2024-09-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Dosing Study of IkT-148009.
Sponsor: ABLi Therapeutics, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: IkT-148009-102
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators